ASX - By Stock
|
PAA Biotech |
Re:
Phase II Begins, Cashed Up with Healey In the Sights of Big Pharma $$$
|
|
pi065509
|
456 |
136K |
21 |
29/09/24 |
29/09/24 |
ASX - By Stock
|
456
|
136K
|
21
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Phase II Begins, Cashed Up with Healey In the Sights of Big Pharma $$$
|
|
pi065509
|
456 |
136K |
18 |
27/09/24 |
27/09/24 |
ASX - By Stock
|
456
|
136K
|
18
|
|
ASX - By Stock
|
GMN |
Re:
Ann: Becoming a substantial holder
|
|
pi065509
|
6 |
1.6K |
3 |
25/09/24 |
25/09/24 |
ASX - By Stock
|
6
|
1.6K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
pi065509
|
97 |
29K |
11 |
12/09/24 |
12/09/24 |
ASX - By Stock
|
97
|
29K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
PAA - General discussions
|
|
pi065509
|
102 |
33K |
13 |
10/09/24 |
10/09/24 |
ASX - By Stock
|
102
|
33K
|
13
|
|
ASX - By Stock
|
PAA |
Re:
PAA - General discussions
|
|
pi065509
|
102 |
33K |
7 |
10/09/24 |
10/09/24 |
ASX - By Stock
|
102
|
33K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
pi065509
|
97 |
29K |
8 |
05/09/24 |
05/09/24 |
ASX - By Stock
|
97
|
29K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
pi065509
|
97 |
29K |
5 |
05/09/24 |
05/09/24 |
ASX - By Stock
|
97
|
29K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Positive Interim Study Results from OLE Study in ALS
|
|
pi065509
|
68 |
20K |
22 |
27/08/24 |
27/08/24 |
ASX - By Stock
|
68
|
20K
|
22
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Phase II Begins, Cashed Up with Healey In the Sights of Big Pharma $$$
|
|
pi065509
|
456 |
136K |
9 |
12/08/24 |
12/08/24 |
ASX - By Stock
|
456
|
136K
|
9
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Phase II Begins, Cashed Up with Healey In the Sights of Big Pharma $$$
|
|
pi065509
|
456 |
136K |
7 |
12/08/24 |
12/08/24 |
ASX - By Stock
|
456
|
136K
|
7
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Phase II Begins, Cashed Up with Healey In the Sights of Big Pharma $$$
|
|
pi065509
|
456 |
136K |
14 |
10/08/24 |
10/08/24 |
ASX - By Stock
|
456
|
136K
|
14
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Phase II Begins, Cashed Up with Healey In the Sights of Big Pharma $$$
|
|
pi065509
|
456 |
136K |
6 |
08/08/24 |
08/08/24 |
ASX - By Stock
|
456
|
136K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Ann: AGM Date & Director Nominations Closing Date for AGM
|
|
pi065509
|
17 |
4.9K |
7 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
17
|
4.9K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Company presenting at Techknow in Sydney (today)/ Melbourne (tomorrow)
|
|
pi065509
|
68 |
15K |
4 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
68
|
15K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Top 100 PAA Shareholders 30 June 2024
|
|
pi065509
|
19 |
7.3K |
6 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
19
|
7.3K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4C & Quarterly Update
|
|
pi065509
|
38 |
9.4K |
7 |
29/07/24 |
29/07/24 |
ASX - By Stock
|
38
|
9.4K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Appendix 4C & Quarterly Update
|
|
pi065509
|
38 |
9.4K |
5 |
29/07/24 |
29/07/24 |
ASX - By Stock
|
38
|
9.4K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust Completes Share Purchase Plan
|
|
pi065509
|
107 |
28K |
8 |
26/07/24 |
26/07/24 |
ASX - By Stock
|
107
|
28K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust Completes Share Purchase Plan
|
|
pi065509
|
107 |
28K |
3 |
26/07/24 |
26/07/24 |
ASX - By Stock
|
107
|
28K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust Completes Share Purchase Plan
|
|
pi065509
|
107 |
28K |
9 |
26/07/24 |
26/07/24 |
ASX - By Stock
|
107
|
28K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust Completes Share Purchase Plan
|
|
pi065509
|
107 |
28K |
13 |
26/07/24 |
26/07/24 |
ASX - By Stock
|
107
|
28K
|
13
|
|
ASX - By Stock
|
PAA |
Re:
Pharmaust - Media & News
|
|
pi065509
|
166 |
59K |
19 |
25/07/24 |
25/07/24 |
ASX - By Stock
|
166
|
59K
|
19
|
|
ASX - By Stock
|
PAA |
Re:
Pharmaust - Media & News
|
|
pi065509
|
166 |
59K |
23 |
25/07/24 |
25/07/24 |
ASX - By Stock
|
166
|
59K
|
23
|
|
ASX - By Stock
|
PAA |
Re:
Pharmaust - Media & News
|
|
pi065509
|
166 |
59K |
36 |
25/07/24 |
25/07/24 |
ASX - By Stock
|
166
|
59K
|
36
|
|
ASX - By Stock
|
PAA |
Re:
Pharmaust - Media & News
|
|
pi065509
|
166 |
59K |
17 |
25/07/24 |
25/07/24 |
ASX - By Stock
|
166
|
59K
|
17
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust Completes Share Purchase Plan
|
|
pi065509
|
107 |
28K |
20 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
107
|
28K
|
20
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust Completes Share Purchase Plan
|
|
pi065509
|
107 |
28K |
19 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
107
|
28K
|
19
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Investor Briefings & Webinar Notice
|
|
pi065509
|
81 |
24K |
5 |
16/07/24 |
16/07/24 |
ASX - By Stock
|
81
|
24K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Investor Briefings & Webinar Notice
|
|
pi065509
|
81 |
24K |
10 |
15/07/24 |
15/07/24 |
ASX - By Stock
|
81
|
24K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Monepantel Selected for Entry into HEALEY ALS Platform Trial
|
|
pi065509
|
64 |
18K |
9 |
15/07/24 |
15/07/24 |
ASX - By Stock
|
64
|
18K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Monepantel Selected for Entry into HEALEY ALS Platform Trial
|
|
pi065509
|
64 |
18K |
3 |
15/07/24 |
15/07/24 |
ASX - By Stock
|
64
|
18K
|
3
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Monepantel Selected for Entry into HEALEY ALS Platform Trial
|
|
pi065509
|
64 |
18K |
22 |
15/07/24 |
15/07/24 |
ASX - By Stock
|
64
|
18K
|
22
|
|
ASX - By Stock
|
GFS |
Re:
Still Registered
|
|
pi065509
|
17 |
7.9K |
0 |
14/07/24 |
14/07/24 |
ASX - By Stock
|
17
|
7.9K
|
0
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
pi065509
|
978 |
275K |
7 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
978
|
275K
|
7
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
pi065509
|
978 |
275K |
14 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
978
|
275K
|
14
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
pi065509
|
978 |
275K |
13 |
04/07/24 |
04/07/24 |
ASX - By Stock
|
978
|
275K
|
13
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
pi065509
|
978 |
275K |
21 |
04/07/24 |
04/07/24 |
ASX - By Stock
|
978
|
275K
|
21
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial
|
|
pi065509
|
978 |
275K |
13 |
26/06/24 |
26/06/24 |
ASX - By Stock
|
978
|
275K
|
13
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust Presentation
|
|
pi065509
|
91 |
25K |
13 |
24/06/24 |
24/06/24 |
ASX - By Stock
|
91
|
25K
|
13
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust Presentation
|
|
pi065509
|
91 |
25K |
14 |
23/06/24 |
23/06/24 |
ASX - By Stock
|
91
|
25K
|
14
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust Presentation
|
|
pi065509
|
91 |
25K |
15 |
23/06/24 |
23/06/24 |
ASX - By Stock
|
91
|
25K
|
15
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust Presentation
|
|
pi065509
|
91 |
25K |
16 |
21/06/24 |
21/06/24 |
ASX - By Stock
|
91
|
25K
|
16
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
pi065509
|
159 |
41K |
5 |
21/06/24 |
21/06/24 |
ASX - By Stock
|
159
|
41K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
pi065509
|
159 |
41K |
2 |
20/06/24 |
20/06/24 |
ASX - By Stock
|
159
|
41K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
pi065509
|
159 |
41K |
8 |
20/06/24 |
20/06/24 |
ASX - By Stock
|
159
|
41K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
pi065509
|
159 |
41K |
7 |
20/06/24 |
20/06/24 |
ASX - By Stock
|
159
|
41K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
pi065509
|
159 |
41K |
13 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
159
|
41K
|
13
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Notice of Extraordinary General Meeting/Proxy Form
|
|
pi065509
|
284 |
80K |
3 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
284
|
80K
|
3
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Notice of Extraordinary General Meeting/Proxy Form
|
|
pi065509
|
284 |
80K |
1 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
284
|
80K
|
1
|
|